West Pharmaceutical Services Inc
WST223.375USD
+1.465+0.66%
Market hours （ET）Quotes delayed by 15 min
16.04BMarket Cap
32.55P/E TTM
More Details of West Pharmaceutical Services Inc Company
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Company Info
Ticker SymbolWST
Company nameWest Pharmaceutical Services Inc
IPO dateJul 27, 1923
Founded at1923
CEOMr. Eric Mark Green
Number of employees10600
Security typeOrdinary Share
Fiscal year-endJul 27
Address530 Herman O. West Drive
CityEXTON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code19341
Phone16105942900
Websitehttps://www.westpharma.com/
Ticker SymbolWST
IPO dateJul 27, 1923
Founded at1923
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+2.44%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+2.56%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+2.57%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+5.97%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
10.46K
+11.41%
Mr. Bernard John Birkett
Mr. Bernard John Birkett
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
7.54K
+9.37%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Lead Independent Director
Lead Independent Director
4.14K
+34.90%
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
2.16K
+98.08%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+2.44%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+2.56%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+2.57%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+5.97%
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
High Value Components
1.30B
45.00%
Standard Packaging
636.50M
22.00%
Contract-Manufactured Products
549.71M
19.00%
Delivery Devices
405.05M
14.00%
By RegionUSD
Name
Revenue
Proportion
United States
1.23B
42.54%
Other European Countries
385.50M
13.32%
Germany
372.50M
12.88%
Other
339.00M
11.72%
Ireland
323.20M
11.17%
France
242.20M
8.37%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
High Value Components
1.30B
45.00%
Standard Packaging
636.50M
22.00%
Contract-Manufactured Products
549.71M
19.00%
Delivery Devices
405.05M
14.00%
Shareholding Stats
Updated: Sun, May 18
Updated: Sun, May 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.81%
BlackRock Institutional Trust Company, N.A.
5.77%
Brown Advisory
4.55%
State Street Global Advisors (US)
4.46%
Walter Scott & Partners Ltd.
3.26%
Other
69.15%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.81%
BlackRock Institutional Trust Company, N.A.
5.77%
Brown Advisory
4.55%
State Street Global Advisors (US)
4.46%
Walter Scott & Partners Ltd.
3.26%
Other
69.15%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
45.38%
Investment Advisor
36.36%
Hedge Fund
5.93%
Pension Fund
3.55%
Research Firm
2.41%
Bank and Trust
1.67%
Sovereign Wealth Fund
1.32%
Insurance Company
0.72%
Endowment Fund
0.62%
Other
2.02%
Institutional Shareholding
Updated: Mon, Jan 20
Updated: Mon, Jan 20
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
1622
71.47M
99.46%
-1.08M
2024Q4
1626
70.93M
98.10%
-2.28M
2024Q3
1603
70.42M
97.07%
-3.49M
2024Q2
1609
70.03M
96.14%
-3.89M
2024Q1
1617
70.47M
96.25%
-3.65M
2023Q4
1622
70.59M
95.41%
-3.14M
2023Q3
1619
70.63M
95.63%
-3.16M
2023Q2
1600
70.17M
94.52%
-5.10M
2023Q1
1586
71.76M
96.63%
-2.52M
2022Q4
1564
71.37M
96.40%
-822.34K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
8.96M
12.39%
-463.00
-0.01%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
4.14M
5.72%
-38.26K
-0.92%
Dec 31, 2024
Brown Advisory
2.55M
3.53%
+266.49K
+11.66%
Dec 31, 2024
State Street Global Advisors (US)
3.25M
4.49%
+32.27K
+1.00%
Dec 31, 2024
Walter Scott & Partners Ltd.
2.42M
3.34%
+40.48K
+1.70%
Dec 31, 2024
Artisan Partners Limited Partnership
3.11M
4.3%
+44.38K
+1.45%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.78M
2.46%
+38.76K
+2.23%
Dec 31, 2024
APG Asset Management N.V.
1.44M
1.99%
-871.45K
-37.74%
Dec 31, 2024
Franklin Advisers, Inc.
1.75M
2.42%
-502.73K
-22.29%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
Amplify Weight Loss Drug & Treatment ETF
4.06%
Motley Fool Mid-Cap Growth ETF
2.65%
VanEck Morningstar Wide Moat Growth ETF
2.6%
VanEck Morningstar Wide Moat ETF
2.09%
First Trust Indxx Medical Devices ETF
1.93%
American Century Mid Cap Growth Impact ETF
1.59%
Invesco S&P 500 Equal Weight Health Care ETF
1.59%
Nuveen ESG Mid-Cap Growth ETF
1.57%
FT Vest S&P 500 Dividend Aristocrats Tgt Inc
1.4%
VanEck Morningstar Wide Moat Value ETF
1.37%
View more
Amplify Weight Loss Drug & Treatment ETF
Proportion4.06%
Motley Fool Mid-Cap Growth ETF
Proportion2.65%
VanEck Morningstar Wide Moat Growth ETF
Proportion2.6%
VanEck Morningstar Wide Moat ETF
Proportion2.09%
First Trust Indxx Medical Devices ETF
Proportion1.93%
American Century Mid Cap Growth Impact ETF
Proportion1.59%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.59%
Nuveen ESG Mid-Cap Growth ETF
Proportion1.57%
FT Vest S&P 500 Dividend Aristocrats Tgt Inc
Proportion1.4%
VanEck Morningstar Wide Moat Value ETF
Proportion1.37%
Dividend
A total of
269.40M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jan 28, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Feb 11, 2025 going ex on Feb 07, 2025
Feb 07, 2025
Feb 11, 2025
Feb 07, 2025
Oct 24, 2024
WST.NB Final Cash Dividend of gross USD 0.21 paid on Nov 20, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 20, 2024
Nov 13, 2024
Apr 25, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Aug 07, 2024 going ex on Jul 31, 2024
Jul 31, 2024
Aug 07, 2024
Jul 31, 2024
Feb 20, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on May 01, 2024 going ex on Apr 23, 2024
Apr 24, 2024
May 01, 2024
Apr 23, 2024
Dec 06, 2023
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 07, 2024 going ex on Jan 30, 2024
Jan 31, 2024
Feb 07, 2024
Jan 30, 2024
Oct 26, 2023
WST.NB Final Cash Dividend of gross USD 0.2 paid on Nov 15, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 15, 2023
Nov 07, 2023
Apr 27, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Aug 02, 2023 going ex on Jul 25, 2023
Jul 26, 2023
Aug 02, 2023
Jul 25, 2023
Mar 03, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on May 03, 2023 going ex on Apr 25, 2023
Apr 26, 2023
May 03, 2023
Apr 25, 2023
Dec 13, 2022
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Feb 01, 2023 going ex on Jan 24, 2023
Jan 25, 2023
Feb 01, 2023
Jan 24, 2023
Oct 27, 2022
WST.NB Final Cash Dividend of gross USD 0.19 paid on Nov 16, 2022 going ex on Nov 08, 2022
Nov 09, 2022
Nov 16, 2022
Nov 08, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
